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The psychometric properties of the Quick Inventory of 
Depressive Symptomatology-Self-Report (QIDS-SR) in patients 
with HBV-related liver disease 
•Original research article•
Background: Comorbid depression in Hepatitis B virus (HBV) is common. Developing accurate and time-
efficient tools to measure depressive symptoms in HBV is important for research and clinical practice in 
China. 
Aims: This study tested the psychometric properties of the Chinese version of the 16-item Quick Inventory of 
Depressive Symptomatology (QIDS-SR) in HBV patients. 
Methods: The study recruited 245 depressed patients with HBV and related liver disease. The severity of 
depressive symptoms was assessed with the Montgomery-Asberg Depression Rating Scale (MADRS) and the 
QIDS-SR. 
Results: Internal consistency (Cronbach’s alpha) was 0.796 for QIDS-SR. The QIDS-SR total score was 
significantly correlated with the MADRS total score (r=0.698, p<0.001). The QIDS-SR showed unidimensional 
measurement properties in exploratory factor analysis. 
Conclusions: The QIDS-SR (Chinese version) has good psychometric properties in HBV patients and appears 
to be useful in assessing depression in clinical settings. 
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1. Introduction
Chronic hepatitis B virus (HBV) infection affects around 
300-400 million people worldwide.[1,2] In China, there 
are approximately 93 million HBV carriers and about 30 
million suffer from chronic hepatitis B.[3] HBV infection 
is progressive and may lead to cirrhosis, liver failure and 
hepatocellular carcinoma, causing significant personal 
suffering and considerable socioeconomic burden.[4] 
In the past decade psychiatric comorbidity in HBV-
infection has gained increasing attention. Preliminary 
evidence indicates that comorbid depression is common 
in Chinese HBV patients,[5] which could be mediated 
by a variety of factors including antiviral medications, 
disease-related physical symptoms and the socio-
economic consequences of high treatment costs.[6,7] 
HBV-related diseases are associated with fatigue, 
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loss of appetite, abdominal pain and psychological 
disturbances, such as low self-esteem.[29] Furthermore, 
discrimination and stigma related to HBV disease often 
affects patients and their families.[30,31] All these factors 
could increase the risk of psychiatric comorbidities, 
particularly depression.[32,33] As depression is eminently 
treatable, particularly when detected early, routine 
depression screening would be important in the medical 
management of HBV patients. 
Numerous studies have examined comorbid 
depression in HBV.[8-14] The measures on depression 
included the Beck Depression Inventory and its short 
version,[15] the Hospital Anxiety and Depression Scale [16] 
and the Zung Self-Rating Depression Scale [17]. 
The 16-item Quick Inventory of Depressive 
Symptomatology–Self-Report (QIDS-SR) is a widely 
used, self-report instrument with well-established 
psychometric properties.[18] The QIDS-SR can reliably 
assess depressive symptoms in the previous week in a 
time-efficient manner in physically healthy psychiatric 
patients.[19,20] However, its psychometric properties 
have not been assessed in medically compromised HBV 
patients. 
The current study set  out to examine the 
psychometric properties of the Chinese version of the 
QIDS-SR in patients with HBV and related liver diseases. 
2. Methods
2.1 Settings and subjects
The study was conducted between June 1, 2014 and 
January 31, 2015 in Beijing YouAn Hospital, which is 
an 800-bed university affiliated teaching hospital for 
infectious diseases. Both inpatients and outpatients 
were consecutively screened to participate. Study entry 
criteria were as follows: (1) age 18 years or above; (2) 
diagnosis of HBV carrier, chronic hepatitis B (CHB), 
hepatitis B cirrhosis or HBV-related Hepatocellular 
Carcinoma (HCC) according to the Guidelines of 
Prevention and Treatment for Chronic Hepatitis B (2010 
version) [21] and the Recommendations of the Asian 
Pacific Association for the Study of the Liver (APASL) 
for the management of hepatocellular carcinoma;[22] 
(3) a total score of 7 or above on the Montgomery-
Asberg Depression Rating Scale (MADRS) indicating at 
least mild depression;[34] (4) ability  to communicate, 
understand the purpose of the study and tolerate a 
one-hour interview. The study protocol was approved 
by the Beijing YouAn Hospital Clinical Research Ethics 
committee. All patients provided written informed 
consent. 
2.2 Instruments and assessment
The Chinese version of the QIDS-SR [18,23] was used to 
measure the severity of depressive symptoms within 
the past week. A total score was computed by adding 
scores of its nine symptom domains: (1)low mood; 
(2) concentration/decision-making; (3) self-outlook; 
(4) thoughts of death or suicide; (5) involvement; (6) 
energy level; (7) sleep (the highest score on any one 
of the four relevant items – sleep onset insomnia, 
mid-nocturnal insomnia, early morning insomnia and 
hypersomnia); (8) appetite/weight change (the highest 
score on any one of the four relevant items – weight 
increase, weight decrease, appetite increase and 
appetite decrease) and (9) agitation/retardation (the 
highest score on any one of the two relevant items – 
psychomotor slowing or psychomotor agitation). The 
total score ranges between 0 and 27, with higher scores 
indicating more severe depressive symptoms. The 
MADRS–Chinese version [24,25] was used to measure the 
severity of depressive symptoms within the past week 
as the reference standard for sensitivity to change of 
depressive symptoms measured by the QIDS-SR. The 
MADRS is a generic measure of severity of depressive 
symptoms and widely used in the general population 
and with patients with medical conditions.[24,25] Higher 
MADRS scores indicate more severe depression. 
2.3 Statistical analysis
Data were analyzed with SPSS version 20.0. Cronbach’s 
alpha was calculated to determine internal consistency. 
Internal consistency was regarded acceptable if the 
Cronbach’s alpha was greater than 0.6.[26] The item-
scale correlations of the QIDS-SR were tested using 
Pearson correlation coefficients. Convergent validity was 
calculated by Pearson correlation between the QIDS-SR 
and MADRS if the scores on the QIDS-RS and the MADRS 
were normally distributed, otherwise the Spearman 
correlation was used. The dimensionality of the QIDS-
SR was measured by Principal Component Analysis to 
obtain the most meaningful original factor structure of 
the QIDS-SR. The scale was unidimensional in patients 
with HBV, if the percentage of total variance explained 
by the first principal component was above 20%.[27] 
3. Results
Altogether, 689 patients were screened; 245 met study 
entry criteria and participated in the study. All of them 
completed the assessment with the QIDS-SR and the 
MADRS. Table 1a shows the basic demographic and 
clinical characteristics of the participants.  There was 
no significant difference in demographic and clinical 
characteristics among the different HBV groups. 
Cronbach’s alpha for the QIDS-SR was 0.796, indicating 
good internal consistency. All domains, if deleted, 
consistently decreased the total scale alpha (Table 1b). 
The QIDS-SR was highly correlated with the MADRS 
(r=0.698, p<0.001), indicating good convergent validity 
for the QIDS-SR. Principal component analysis was 
carried out to examine whether the QIDS-SR was 
unidimensional. The percentage of total variance 
explained by the first principal component for the QIDS-
SR was 27.4%, thus indicating unidimensionality of the 
QIDS-SR.[27] 
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Figure 1. Flowchart of study
812 HBV related patients
92 patients declined  to partcipate;
31 did not complete;
62 HBV carrier
42 did not have 
depressive 
689 included in analysis
241 Chronic hepatitis B
173 did not have 
depressive symptoms 
198 HBV-related hepatitis B 
131 did not have depressive 
symptoms
188 HBV-related HCC
98 did not have 
depressive 
20 HBV carrier 68 Chronic hepatitis B 67 HBV-related hepatitis B 90 HBV-related HCC
Table1a. Basic demographic and clinical characteristics of the study sample (n=245)
whole sample
HBV carrier
(n=20)
Chronic 
hepatitis B
(n=68)
HBV-related 
cirrhosis
(n=67)
HBV-related HCC
(n=90)
N(%) N(%) N(%) N(%) N(%)
Inpatients 157(64.1) 0(0) 0(0) 67(100.0) 90(100)
Male 179(73.1) 8(40) 40(58.8) 54(80.6) 77(85.6)
Married 205(83.7) 14(70) 54(79.4) 59(88.1) 78(86.7)
Local residents 104(42.4) 7(35) 23(33.8) 25(37.3) 49(54.4)
Living alone 12(4.9) 1(5) 1(1.5) 7(10.4) 3(3.3)
Personal income <3000 yuan 87(35.5) 6(30) 18(26.5) 23(34.3) 40(44.4)
Having health insurance’ to 
‘Health insurance coverage 4(1.6) 0(0) 0(0) 2(3) 2(2.2)
Family history of psychiatric 
disorders 8(3.3) 0(0) 5(7.4) 1(1.5) 2(2.2)
Current alcohol use 47(19.2) 2(10) 18(26.5) 13(19.4) 14(15.6)
Mean(SD) Mean(SD) Mean(SD) Mean(SD) Mean(SD)
Age (years) 48.3(13.7) 34.4(10.4) 37.2(11.0) 51.0(10.6) 57.7(9.0)
Education (years) 10.8(3.8) 11.5(4.3) 11.6(3.3) 9.9(4.5) 10.8(3.3)
Age of onset of HBV (years) 34.1(15.0) 20.9(8.0) 27.0(14.2) 37.6(13.9) 39.8(13.8)
Duration of HBV-related liver 
disease (years) 14.3(11.4) 13.6(8.9) 10.3(8.8) 13.9(12.4) 17.7(11.9)
Number of hospitalizations 2.6(4.1) 0.1(0.3) 0.4(0.7) 3.2(5.9) 4.3(3.4)
MADRS total 14.8(7.3) 14.8(10.5) 14.3(6.7) 15.7(6.7) 14.5(7.2)
QIDS-SR total 8.7(3.9) 8.8(4.3) 7.6(3.8) 10.2(4.1) 8.5(3.6)
1 USD=6 Yuan; HCC=Hepatocellular Carcinoma; MADRS=Montgomery-Asberg Depression Scale; QIDS-SR= Quick Inventory of 
Depressive Symptomatology–Self-Report; SF-12=Medical Outcomes Study Short Form 12
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4. Discussion
4.1 Main findings
To the best of our knowledge, this was the first study 
that examined the psychometric properties of the 
QIDS-SR in patients with HBV. The findings indicate that 
QIDS-SR is a reliable and valid instrument for screening 
depressive symptoms in HBV patients. 
Acceptable internal consistency (>0.65) was 
found for the QIDS-SR in testing HBV patients, which 
is consistent with the findings in clinically depressed 
samples.[23] Item-to-total score correlations showed that 
the sleep and appetite/weight domains had the lowest 
correlation, confirming other findings in depression.
[18,28] Moreover, item-to-total score correlations of sad 
mood and involvement had the highest correlation, 
which is also consistent with the results found in 
depression.[19] Compared to the MADRS, the QIDS-
SR showed good convergent validity. This is consistent 
with initial structure obtained in depression where the 
the Hamilton Depression Rating Scale (HAMD) was 
used as the comparator rating instrument.[18] Principal 
component analysis identified one major factor from 
the QIDS-SR, suggesting that the factorial structure of 
the QIDS-SR in HBV patients is the same as found in 
depression.[18,19]
4.2 Limitations 
Due to the following limitations, the results of this study 
need to be viewed with caution. First, only patients in 
one hospital were included, therefore the findings are 
not applicable to all areas of China. Second, test-retest 
reliability was not measured because most depressed 
patients were treated once they were identified. Finally, 
useful information, such as use of antidepressants and 
other medications or comorbid anxiety or other physical 
complications, were not recorded. 
4.3 Implications
In conclusion, the Chinese version of the QIDS-SR is 
an effective tool with good validity and reliability in 
a clinical sample. Considering that the QIDS-SR could 
provide independent information about depressive 
symptoms in a time-efficient manner, it could be useful 
in assessing depression in patients with HBV infection.
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Table 1b. Quick Inventory of Depressive Symptomatology (QIDS-SR) scores in HBV patients
n=245
Mean(Standard Deviation) Item-total correlation p Alpha if item deleted
Sleep 2.1(0.8) 0.27** p<0.001 0.79
Low mood 1.2(0.7) 0.52** p<0.001 0.75
Appetite / weight 1.3(0.9) 0.35** p<0.001 0.78
Concentration / Decision making 0.7(0.6) 0.59** p<0.001 0.74
Self outlook 0.8(0.8) 0.48** p<0.001 0.75
Thoughts of death or suicide 0.3(0.6) 0.49** p<0.001 0.75
Involvement 0.8(0.8) 0.57** p<0.001 0.74
Energy level 1.0(0.5) 0.47** p<0.001 0.76
Agitation / retardation 0.6(0.7) 0.52** p<0.001 0.75
Total score --- ---
*<0.05; **<0.001
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背景：乙型肝炎病毒（HBV）感染伴发抑郁症是一种
常见的现象。建立精确并且有时效的工具，用以评估
HBV患者抑郁症状，对研究和临床实践是非常重要的。
目的：这项研究测试了抑郁症状快速评定量表自评版
（QIDS-SR）在乙型肝炎患者中使用的心理测量学特性。
方法：这项研究招募了 245名患有乙型肝炎病毒和
相关肝病的抑郁症患者。采用蒙特玛莉抑郁评定量表
（MADRS）和 QIDS-SR评估抑郁症状的严重程度。 
结果：QIDS-SR的内部一致性（(Cronbach α）为 0.796.
其总分与 MADRS总分显著相关 r=0.698, p<0.001）。
探索性因素分析的 QIDS-SR显示一维测量性能
 结论：QIDS-SR（中文版）在乙型肝炎患者中有良好
的心理测量学特性，并且在评估临床抑郁症方面是有
用的。
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